InvestorsHub Logo
Followers 19
Posts 628
Boards Moderated 0
Alias Born 04/17/2013

Re: Whalatane post# 235428

Tuesday, 12/17/2019 10:59:05 PM

Tuesday, December 17, 2019 10:59:05 PM

Post# of 425892
Whal'

AMARIN knows that 2019 will produce $425-440 sales revenue.... all conferences JT has attended, all CC's they have had since submittal of SDNA, all Medical shows JT has been on,etc, have questioned him concerning him about potential API supply to cover increased scripts.... take into account just last weeks 8o,ooo scripts, approval of VASCEPA starting MONDAY 12-16,2019, Approvals from AHA,ACA,ALA,ADA,etc, sales to be gained from scripts sold each week to Lovasa/generics coming to AMARIN..... NOBODY expects sales of $650-700 for 2020.... even the analysts reporting stated that 2020 projections are low..... and sales people in AMARIN have said it is to low... THE MARKET EXPECTS CLOSE TO 1 BIL. AMARIN (DID'T) lowered guidance, they gave A low guidance .... can you tell the difference???

Monday,downward pressure on price was lower guidance and after 4:00 o'clock after the market closed then information came out concerning a patent settlement, continuing downward pressure today (tues)... two separate situations piggybacking on each other....

Made a perfect BEAR raid by short's/mm....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News